Sawai Group Holdings Co., Ltd. (TYO:4887)
Japan · Delayed Price · Currency is JPY 1,620.50
-5.50 (-0.34%)
Aug 25, 2026, 3:24 PM JST
Sawai Group Holdings Company Description
Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the manufacture and sale of pharmaceuticals.
The company offers generic drugs in various dosage forms for therapeutic areas comprising cardiovascular and antibiotic preparations, central nervous system drugs, other metabolic drugs, digestive tract medicines, blood and body fluid medications, allergy medications, respiratory medicine, vitamin supplements, oncology drugs, chemotherapeutic agents, genitourinary and anal drugs, and others.
It sells its generic drugs through distributors, wholesalers, and retailers. Sawai Group Holdings Co., Ltd. was founded in 1929 and is headquartered in Osaka, Japan.
Sawai Group Holdings Co., Ltd.
| Country | Japan |
| Founded | 1929 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 3,630 |
| CEO | Mitsuo Sawai |
Contact Details
Address: 5-2-30, Miyahara Osaka, 532-0003 Japan | |
| Phone | 81 6 6105 5818 |
| Website | sawaigroup.holdings |
Stock Details
| Ticker Symbol | 4887 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3323040000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Mitsuo Sawai | Chief Executive Officer |
| Taku Nakaoka | Chief Financial Officer |
| Mitsuo Sawai | Chief Operating Officer |
| Yasushi Kora | Head of Investor Relations |